Assenagon Asset Management
CRMD icon

Assenagon Asset Management’s CorMedix CRMD Stock Holding History

Assenagon Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-302,508
Closed -$3.52M – 1134
2025
Q4 		$3.52M Buy
302,508
+78,447
+35% +$867K ﹤0.01% 709
2025
Q3 		$2.61M Buy
+224,061
New +$2.71M ﹤0.01% 778

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Assenagon Asset Management's CRMD Position: Q1 2026 in Review

Assenagon Asset Management sold out of CorMedix (CRMD) in Q1 2026, closing a stake of 302,508 shares — an estimated $3.52M sold.

Assenagon Asset Management first reported a position in CRMD in Q3 2025 and held it in 2 quarters. The position peaked at $3.52M in Q4 2025. 188 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • Assenagon Asset Management reported no remaining CorMedix position as of Q1 2026 after selling out during the quarter.
  • Assenagon Asset Management sold 302,508 CorMedix shares in Q1 2026, an estimated $3.52M.
  • Assenagon Asset Management first reported a position in CorMedix in Q3 2025 and held it in 2 quarters.
  • Assenagon Asset Management's CorMedix position peaked at $3.52M in Q4 2025.
  • 188 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.